Trastuzumab, 10 mg

Its specificity ensures that the treatment directly addresses the root cause of HER2-positive breast cancer, leading to improved patient outcomes. This targeted therapy offers hope for those seeking effective management of this aggressive form of cancer.

Formulation & Format Details

Trastuzumab is supplied for A to Z work where the documented pack format applies.

Common Application Settings

• Facilities already using A to Z products comparable to Trastuzumab.
• A to Z tasks that call for Trastuzumab by name and pack size.
• Maintenance cycles that include Trastuzumab in the supply list.
• Sites where Trastuzumab matches the listed A to Z category.